Two Sigma Investments, LP Vor Biopharma Inc. Transaction History

Two Sigma Investments, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.09 - $5.33 $21,509 - $37,102	6,961 Added 32.95%	28,090 $86,000
Q1 2023 May 15, 2023	SELL	$4.68 - $6.96 $155,722 - $231,587	-33,274 Reduced 61.16%	21,129 $113,000
Q4 2022 Feb 14, 2023	BUY	$3.77 - $7.43 $150,034 - $295,691	39,797 Added 272.47%	54,403 $361,000
Q3 2022 Nov 14, 2022	BUY	$3.9 - $5.52 $56,963 - $80,625	14,606 New	14,606 $58,000

47.9M

1.5K

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $27M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.